PAR paradigm biopharmaceuticals limited..

Our CEO has been treated with IPPS for 8 years, page-13

  1. 896 Posts.
    lightbulb Created with Sketch. 277
    A key factor I look for when investing in a company is the alignment of senior management with shareholder interests. The best indicator of this is that management are also major shareholders. In this case, it is very positive that Paul Rennie is the largest shareholder.

    Reading that Paul Rennie uses and has benefitted from iPPS further strengthens this alignment. He clearly sees the benefit of iPPS first hand and is intent on making it available to others. His large shareholding provides the incentive for distributing it as widely as possible and doing so very profitably.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
0.010(2.44%)
Mkt cap ! $166.9M
Open High Low Value Volume
40.0¢ 42.0¢ 40.0¢ $168.2K 411.3K

Buyers (Bids)

No. Vol. Price($)
1 3500 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 50665 2
View Market Depth
Last trade - 16.11pm 18/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.